Dr. Olson completed Hematology and Oncology fellowship at Memorial Sloan-Kettering in 2013 where her research focus was related to optimization of umbilical cord blood transplantation and infectious complications following hematopoietic stem cell transplant in adults. She currently is an Associate Professor of Medicine in the Department of Stem Cell Transplantation and Cellular Therapy where she oversees clinical research related to cord blood transplantation, mesenchymal stem cell manipulation and cellular therapy. Dr. Olson is the Principal Investigator for several cellular therapy trials including a Phase I trial of mesenchymal stem cells transfected with plasmid containing interferon beta for the treatment of refractory epithelial ovarian cancer, an international, multi-institutional, Phase III study evaluating the use of cord blood derived mesenchymal stem cell expansion to expedite hematopoietic engraftment following stem cell transplantation, a Phase I trial of IV mesenchymal stem cells for the use of cardiac regeneration following chemotherapy-induced cardiomyopathy and a Phase II trial of cytotoxic T-lymphocytes in the treatment of BK and JC virus. Dr. Olson has institutional funding and extramural grant support.